VISIT JANSSEN GLOBAL FINLAND change location ▼ SEARCH Coronavirus news Welcome to Janssen Finland's website INFORMATION ABOUT US THERAPY AREAS PRODUCTS MEDICAL INFORMATION SERVICE MEDIA OPENNESS Coronavirus vaccine READ MORE Contact us Media Janssen Medical Cloud CURRENT AFFAIRS Basic allowance for Erleada 1.11. From 2021 also for the treatment of metastatic hormone-sensitive prostate cancer Country Director Nina Ekholm-Wenberg trusts in the power of cooperation At Janssen SuomiArena: What does Korona cause for mental health? SEE ALL THE NEWS Tweets by JanssenFinland Work with us ADDRESS Janssen-Cilag Oy Vaisalantie 2 02130 Espoo Text messages only: +358 45 73 950 730 Phone +358 20 7531 300 Fax +358 20 753 1301 Email: jacfi@its.jnj.com PRIVACY POLICY WEBSITE TERMS OF USE COOKIE POLICY CONTACT INFORMATION JANSSEN MEDICAL CLOUD FOLLOW US: Twitter COOKIE SETTINGS This page works best with Internet Explorer 10.0 or later. © Janssen-Cilag Oy 2019. This page has been published by Suomen Janssen-Cilag Oy, which is also responsible for its content. This site is intended for use by persons residing in the European Union. Janssen-Cilag Oy * PO Box 15 * 02621 Espoo * Telephone: +358 20 7531 300. Text messages only: +358 45 7395 0730 * Fax: +358 20 7531 301 Email: jacfi@its.jnj.com Last updated: November 26, 2021 We care about your privacy For the best experience, we want to use cookies to learn how we can improve our site, provide relevant content, and enable social media functionality and advertising. For more information (including sharing information with partners) and changing settings, see “Cookie Settings”. Click “Accept” if you accept or “Reject” if you only want to use the necessary cookies. Discard Accept Cookie settings